David S Perlin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David S Perlin

Showing results (281-290 of 284) with videos related to

Pageof 29

Sort By:

You have reached the last page of results.This site can display upto 284 results.

Viruses|July 27, 2024

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.

Nature|December 11, 2024

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferaseCindy Meyer, Aitor Garzia, Michael W Miller, et al.

JCI Insight|February 11, 2021

Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasmaMichele L Donato, Steven Park, Melissa Baker, et al.

Journal of Medicinal Chemistry|February 16, 2024

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.

Pageof 29

Search research articles

Showing results (281-290 of 284) with videos related to

Sort By:

Pageof 29

You have reached the last page of results.This site can display upto 284 results.

Viruses|July 27, 2024

Novel Pan-Coronavirus 3CL Protease Inhibitor MK-7845: Biological and Pharmacological ProfilingNadine Alvarez, Gregory C Adam, John A Howe, et al.

Nature|December 11, 2024

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferaseCindy Meyer, Aitor Garzia, Michael W Miller, et al.

JCI Insight|February 11, 2021

Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasmaMichele L Donato, Steven Park, Melissa Baker, et al.

Journal of Medicinal Chemistry|February 16, 2024

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.

Pageof 29